Trials / Conditions / Radiation Retinopathy

Radiation Retinopathy

11 registered clinical trials studyying Radiation Retinopathy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for NCT05844982	Jaeb Center for Health Research	Phase 3
Withdrawn	Steroids for Early Treatment of Radiation Retinopathy NCT03238157	The Cleveland Clinic	Phase 2 / Phase 3
Unknown	Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posteri NCT04120636	Targeted Therapy Technologies, LLC	Phase 1
Unknown	Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole NCT04120311	Targeted Therapy Technologies, LLC	Phase 1
Unknown	Intravitreal Aflibercept Injection for Radiation Retinopathy Trial NCT03085784	Amy C Schefler, MD	Phase 2
Completed	Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Inje NCT02222610	Greater Houston Retina Research	Phase 2
Terminated	Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma NCT01471054	Arman Mashayekhi	Phase 2
Completed	Intravitreal Aflibercept Injection for Radiation Retinopathy NCT01579760	Washington University School of Medicine	Phase 1
Completed	High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy NCT01334879	The New York Eye Cancer Center	Phase 1
Completed	Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melan NCT00750399	The New York Eye Cancer Center	Phase 1
Unknown	Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy NCT00540930	Shields, Shields and Associates	Phase 4